Key Takeaways
- • Healthcare IT has delivered superior risk-adjusted returns compared to other healthcare subsectors and broader industries since 2017, with deal volumes expanding to nearly 20% of healthcare transactions in 2025 from 15% in 2021.
- • Leading PE investors are achieving Rule of 60 outcomes through three core levers: pricing and packaging optimization, cross-selling expansion, and AI-enabled growth and margin expansion—moving beyond end-user adoption as the sole return driver.
- • Flagship 2025 transactions underscore sector momentum: Warburg Pincus sold a majority stake in ModMed (specialty EMR provider) to Clearlake Capital and Bain Capital; Bain Capital acquired HealthEdge from Blackstone and merged it with HealthProof (payer-focused IT); and Bain Capital invested in Softway Medical Group in France.
- • Generative AI presents dual value creation opportunities—top-line revenue acceleration and bottom-line margin expansion for healthcare IT providers—alongside navigable downside risks that disciplined investors must address during underwriting and portfolio management.
- • Consistent, disciplined value creation focus from deal underwriting through exit distinguishes the highest-returning healthcare IT investments, with strong fundamentals supporting robust deal activity across macroeconomic cycles.
Summary
Healthcare IT has emerged as a persistently outperforming investment segment within both the broader healthcare sector and alternative asset classes more generally. According to Bain & Company's 2026 Global Healthcare Private Equity Report, healthcare IT returns have exceeded those of other healthcare subsectors since 2017. This durability is reflected in transaction activity: deal volumes reached nearly 20% of all healthcare transactions in 2025, up from 15% in 2021, demonstrating sustained investor conviction despite varied macroeconomic conditions.
The mechanisms driving superior returns have evolved beyond simple adoption metrics. Bain's analysis identifies three critical value creation levers that distinguish winning investments: pricing and packaging optimization, cross-selling expansion across customer bases, and AI-enabled growth coupled with margin expansion. This framework underscores that end-user adoption alone no longer generates the returns required to achieve Rule of 60 outcomes—a benchmark institutional investors use to evaluate PE fund performance.
2025 proved a landmark year for large-scale, systems-of-record transactions across payers, providers, and life sciences platforms. In North America, Warburg Pincus divested a majority interest in ModMed, a specialty-focused electronic medical records provider, to Clearlake Capital and Bain Capital. Concurrently, Bain Capital acquired HealthEdge from Blackstone and merged it with HealthProof, consolidating payer-focused IT capabilities. In Europe, Bain Capital deployed capital into Softway Medical Group, a health information systems and EMR provider headquartered in France, signaling geographic diversification within the healthcare IT vertical.
Generative AI represents a critical inflection point for the healthcare IT investment thesis. The technology offers dual pathways to value creation: accelerating top-line revenue through enhanced service delivery and expanding bottom-line margins through operational efficiency. However, investors must navigate associated downside risks through disciplined underwriting and active portfolio management. Bain's research emphasizes that consistent, disciplined focus on value creation—beginning at underwriting and extending through exit—is the primary differentiator between highest-returning deals and the broader market. This operational rigor, combined with secular tailwinds from healthcare digitalization and regulatory compliance requirements, positions healthcare IT as a durable PE investment category.
The mechanisms driving superior returns have evolved beyond simple adoption metrics. Bain's analysis identifies three critical value creation levers that distinguish winning investments: pricing and packaging optimization, cross-selling expansion across customer bases, and AI-enabled growth coupled with margin expansion. This framework underscores that end-user adoption alone no longer generates the returns required to achieve Rule of 60 outcomes—a benchmark institutional investors use to evaluate PE fund performance.
2025 proved a landmark year for large-scale, systems-of-record transactions across payers, providers, and life sciences platforms. In North America, Warburg Pincus divested a majority interest in ModMed, a specialty-focused electronic medical records provider, to Clearlake Capital and Bain Capital. Concurrently, Bain Capital acquired HealthEdge from Blackstone and merged it with HealthProof, consolidating payer-focused IT capabilities. In Europe, Bain Capital deployed capital into Softway Medical Group, a health information systems and EMR provider headquartered in France, signaling geographic diversification within the healthcare IT vertical.
Generative AI represents a critical inflection point for the healthcare IT investment thesis. The technology offers dual pathways to value creation: accelerating top-line revenue through enhanced service delivery and expanding bottom-line margins through operational efficiency. However, investors must navigate associated downside risks through disciplined underwriting and active portfolio management. Bain's research emphasizes that consistent, disciplined focus on value creation—beginning at underwriting and extending through exit—is the primary differentiator between highest-returning deals and the broader market. This operational rigor, combined with secular tailwinds from healthcare digitalization and regulatory compliance requirements, positions healthcare IT as a durable PE investment category.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.